Showing results (1491-1500 of 1,826) with videos related to

Sort By:
Pageof 183
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 23, 2025
Radiotherapy quality assurance of the prospective randomised EORTC-1219/DAHANCA-29 trial: an individual case review analysisNajlaa Alyamani, André Abrunhosa-Branquinho, Coreen Corning, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 25, 2019
Role of Age and Hematopoietic Cell Transplantation-Specific Comorbidity Index in Myelodysplastic Patients Undergoing an Allotransplant: A Retrospective Study from the Chronic Malignancies Working Party of the European Group for Blood and Marrow TransplantationMartin Carré, Raphaël Porcher, Jürgen Finke, et al.
Haematologica|August 18, 2025
Selection of unrelated donors for allogeneic transplantation using post-transplant cyclophosphamide in acute lymphoblastic leukemia: An analysis by the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationJaime Sanz, Allain-Thibeault Ferhat, Alexander Kulagin, et al.
Communications Medicine|July 31, 2025
A comprehensive multifaceted technical evaluation framework for implementation of auto-segmentation models in radiotherapyRobert Poel, Elias Rüfenacht, Stefan Scheib, et al.
Haematologica|June 24, 2021
Improved outcome of patients with graft-versus-host disease after allogeneic hematopoietic cell transplantation for hematologic malignancies over time: an EBMT mega-file studyHildegard T Greinix, Dirk-Jan Eikema, Linda Koster, et al.
Cancer|May 25, 2022
Additional cytogenetic features determine outcome in patients allografted for TP53 mutant acute myeloid leukemiaJustin Loke, Myriam Labopin, Charles Craddock, et al.
Disease Markers|June 14, 2019
Immune Exclusion Is Frequent in Small-Cell Carcinoma of the BladderTim Mandelkow, Niclas C Blessin, Eva Lueerss, et al.
Clinical and Translational Radiation Oncology|September 3, 2024
Clinical management of oligometastatic cancer: Applying multidisciplinary tumor board recommendations in practiceSebastian M Christ, Minsu Breitenstein, Philip Heesen, et al.
Haematologica|March 5, 2026
Impact of FMS-like tyrosine kinase 3 inhibitor maintenance on post-transplant outcomes in acute myeloid leukemia with FMS-like tyrosine kinase 3 mutations: a real-world German registry analysis highlighting sorafenibRadwan Massoud, Sarah Flossdorf, Franziska Hanke, et al.
Bone Marrow Transplantation|April 8, 2026
Haploidentical transplantation with post-transplant cyclophosphamide is not inferior to 9/10-MUD transplantation with ATG in patients with myeloid malignanciesAndrea Gantner, Svenja Labuhn, Daniel Fürst, et al.
Pageof 183